0000950170-24-094079.txt : 20240808
0000950170-24-094079.hdr.sgml : 20240808
20240808163004
ACCESSION NUMBER: 0000950170-24-094079
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240806
FILED AS OF DATE: 20240808
DATE AS OF CHANGE: 20240808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Basile Edward M
CENTRAL INDEX KEY: 0001773661
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38891
FILM NUMBER: 241188932
MAIL ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TransMedics Group, Inc.
CENTRAL INDEX KEY: 0001756262
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
BUSINESS PHONE: 9785520900
MAIL ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
4
1
ownership.xml
4
X0508
4
2024-08-06
0001756262
TransMedics Group, Inc.
TMDX
0001773661
Basile Edward M
C/O TRANSMEDICS GROUP, INC.
200 MINUTEMAN ROAD
ANDOVER
MA
01810
true
false
false
false
true
Common Stock
2024-08-06
4
M
false
6750
28.12
A
7482
D
Common Stock
2024-08-06
4
S
false
1830
148.26
D
5652
D
Common Stock
2024-08-06
4
S
false
2383
149.71
D
3269
D
Common Stock
2024-08-06
4
S
false
1000
150.7
D
2269
D
Common Stock
2024-08-06
4
S
false
1537
151.89
D
732
D
Stock Option (Right to Buy)
28.12
2024-08-06
4
M
false
6750
0.00
D
2032-06-01
Common Stock
6750
6750
D
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $147.76 to $148.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $149.21 to $150.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $150.50 to $151.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $151.80 to $152.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The option is fully vested.
By: /s/ Stephen Gordon, Attorney-in-Fact
2024-08-08